000 | 01237 a2200325 4500 | ||
---|---|---|---|
005 | 20250517225007.0 | ||
264 | 0 | _c20190409 | |
008 | 201904s 0 0 eng d | ||
022 | _a1474-4457 | ||
024 | 7 |
_a10.1016/S1473-3099(18)30340-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWhiley, David M | |
245 | 0 | 0 |
_aGenetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin. _h[electronic resource] |
260 |
_bThe Lancet. Infectious diseases _c07 2018 |
||
300 |
_a717-718 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aAzithromycin _xtherapeutic use |
650 | 0 | 4 |
_aCeftriaxone _xtherapeutic use |
650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
650 | 0 | 4 |
_aGonorrhea _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aNeisseria gonorrhoeae _xdrug effects |
700 | 1 | _aJennison, Amy | |
700 | 1 | _aPearson, Julie | |
700 | 1 | _aLahra, Monica M | |
773 | 0 |
_tThe Lancet. Infectious diseases _gvol. 18 _gno. 7 _gp. 717-718 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1473-3099(18)30340-2 _zAvailable from publisher's website |
999 |
_c28602722 _d28602722 |